Streetbeat News

ABL

Abacus Life, Inc.

Industry

Insurance - Life

Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

Open

7.91

Mkt cap

746M

Volume

98K

High

8.00

P/E Ratio

-36.09

52-wk high

13.25

Low

7.83

Div yield

N/A

52-wk low

7.07

Abacus Life, Inc. (NASDAQ: ABL) has completed its acquisition of Carlisle Management Company S.C.A., a Luxembourg-based investment fund manager with over $2 billion in assets under management. This acquisition is part of Abacus's strategy to drive long-term growth and diversify its offerings in the global alternative asset-management space.

Portfolio Pulse from

December 02, 2024 | 4:00 pm

Abacus Life, Inc. (NASDAQ: ABL) has received regulatory non-objection for its acquisition of Carlisle Management Company S.C.A., with the deal expected to close on December 2, 2024. This acquisition will enhance Abacus's position in the life settlement investment space.

Portfolio Pulse from

November 26, 2024 | 3:00 pm

Abacus Life, Inc. (NASDAQ: ABL) has successfully closed an oversubscribed public offering of 12,500,000 shares, raising approximately $100 million. The company sold 10,000,000 shares, raising $80 million, while selling stockholders sold 2,500,000 shares, raising $20 million.

Portfolio Pulse from

November 25, 2024 | 10:45 pm

Abacus Life, Inc. (NASDAQ: ABL) announced the pricing of its public offering of 12.5 million shares at $8.00 per share, aiming to raise approximately $100 million. The offering includes shares from both the company and certain stockholders.

Portfolio Pulse from

November 22, 2024 | 12:45 am

Abacus Life, Inc. (NASDAQ: ABL) has announced a public offering of 12.5 million shares of common stock, with 10 million shares sold by the company and 2.5 million by existing stockholders. An option for underwriters to purchase an additional 1.875 million shares is also available.

Portfolio Pulse from

November 21, 2024 | 9:15 pm

Wall Street analysts have set an average price target for Abacus Life, Inc. (ABL) indicating a potential upside of 59.5%. This is supported by positive trends in earnings estimate revisions, suggesting a possible increase in the stock price.

Portfolio Pulse from

November 21, 2024 | 4:15 pm

Abacus Life, Inc. (NASDAQ:ABL) held its Q3 2024 earnings conference call on November 7, 2024. Key participants included Robert Phillips, Jay Jackson, and Bill McCauley. Analysts from Piper Sandler, TD Cowen, and Northland Securities participated in the call.

Portfolio Pulse from

November 09, 2024 | 10:30 am

Abacus Life, Inc. (ABL) reported Q3 earnings of $0.20 per share, surpassing the Zacks Consensus Estimate of $0.14. This marks a significant improvement from $0.01 per share a year ago.

Portfolio Pulse from

November 08, 2024 | 1:30 am

Abacus Life, Inc. reported strong third-quarter 2024 results with a 33% increase in total revenue to $28.1 million. Despite a GAAP net loss of $5.1 million due to a non-cash increase in warrant liability, the company achieved a 65% growth in adjusted net income to $14.9 million and a 54% increase in adjusted EBITDA to $16.7 million.

Portfolio Pulse from

November 07, 2024 | 9:30 pm

Northland Capital Markets has initiated coverage on Abacus Life (NASDAQ:ABL) with an Outperform rating and set a price target of $13.5.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 5:05 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.